Literature DB >> 12472792

Severe bone disease and low bone mineral density after juvenile renal failure.

Jaap W Groothoff1, Martin Offringa, Berthe L F Van Eck-Smit, Mariken P Gruppen, Nicole J Van De Kar, Eric D Wolff, Marc R Lilien, Jean Claude Davin, Hugo S A Heymans, Friedo W Dekker.   

Abstract

BACKGROUND: Little is known about the late effects of juvenile end-stage renal disease (ESRD) on bone integrity. To establish clinical manifestations of metabolic bone disease and bone mineral density (BMD) in young adult patients with juvenile ESRD, we performed a long-term outcome study.
METHODS: A cohort was formed of all Dutch patients with onset of ESRD between 1972 and 1992 at age 0 to 14 years, born before 1979. Data were collected by review of medical charts, current history, physical examination, and performing dual energy x-ray absorptiometry (DEXA) of the lumbar spine and the femoral neck.
RESULTS: Clinical information was retrieved in 247 out of 249 patients. Of all of these patients, 61.4% had severe growth retardation (<-2 SD), 36.8% had clinical symptoms of bone disease, and 17.8% were disabled by bone disease. Growth retardation and clinical bone disease were associated with a long duration of dialysis. DEXA was performed in 140 out of 187 living patients. Mean BMD +/- SD corrected for gender and age (Z score) of the lumbar spine was -2.12 +/- 1.4 and of the femoral neck was -1.77 +/- 1.4. A low lean body mass was associated with a low lumbar spine and a low femoral neck BMD; male gender, physical inactivity and aseptic bone necrosis were associated with a low lumbar spine BMD.
CONCLUSION: Bone disease is a major clinical problem in young adults with pediatric ESRD. Further follow-up is needed to establish the impact of the low bone mineral densities found in these patients.

Entities:  

Mesh:

Year:  2003        PMID: 12472792     DOI: 10.1046/j.1523-1755.2003.00727.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  44 in total

1.  Skeletal status in adolescents with end-stage renal failure: a longitudinal study.

Authors:  Wojciech Pluskiewicz; Piotr Adamczyk; Bogna Drozdzowska; Krystyna Szprynger; Maria Szczepańska; Zenon Halaba; Dariusz Karasek
Journal:  Osteoporos Int       Date:  2004-06-25       Impact factor: 4.507

2.  Bone mineral density in children with chronic renal failure.

Authors:  Simon Waller; Deborah Ridout; Lesley Rees
Journal:  Pediatr Nephrol       Date:  2006-09-15       Impact factor: 3.714

Review 3.  Watching bone cells at work: what we can see from bone biopsies.

Authors:  Frank Rauch
Journal:  Pediatr Nephrol       Date:  2006-03-07       Impact factor: 3.714

4.  Longitudinal assessment of bone quality in pediatric patients with chronic kidney disease in relation to treatment modality.

Authors:  Chrysa Gkogka; Athanasios Christoforidis; Nikoleta Printza; Konstantinos Kollios; Eirini Kazantzidou; Fotios Papachristou
Journal:  J Bone Miner Metab       Date:  2014-05-25       Impact factor: 2.626

Review 5.  Defective skeletal mineralization in pediatric CKD.

Authors:  Katherine Wesseling-Perry
Journal:  Curr Osteoporos Rep       Date:  2015-04       Impact factor: 5.096

Review 6.  Minimizing bone abnormalities in children with renal failure.

Authors:  Helena Ziólkowska
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

7.  Skeletal effects and growth in children with chronic kidney disease: a 5-year prospective study.

Authors:  Diana Swolin-Eide; Sverker Hansson; Per Magnusson
Journal:  J Bone Miner Metab       Date:  2012-12-10       Impact factor: 2.626

Review 8.  Bone disease in pediatric chronic kidney disease.

Authors:  Katherine Wesseling-Perry
Journal:  Pediatr Nephrol       Date:  2012-10-14       Impact factor: 3.714

9.  Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis.

Authors:  Katherine Wesseling-Perry; Renata C Pereira; Hejing Wang; Robert M Elashoff; Shobha Sahney; Barbara Gales; Harald Jüppner; Isidro B Salusky
Journal:  J Clin Endocrinol Metab       Date:  2008-12-02       Impact factor: 5.958

Review 10.  The osteocyte in CKD: new concepts regarding the role of FGF23 in mineral metabolism and systemic complications.

Authors:  Katherine Wesseling-Perry; Harald Jüppner
Journal:  Bone       Date:  2012-10-16       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.